Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India
· Delayed Price · Currency is INR 210.70
-3.65 (-1.70%)
Mar 9, 2026, 3:21 PM IST
NSE:MADHAVBAUG Revenue
Vaidya Sane Ayurved Laboratories had revenue of 499.44M INR in the half year ending September 30, 2025, a decrease of -2.26%. This brings the company's revenue in the last twelve months to 979.90M, up 8.84% year-over-year. In the fiscal year ending March 31, 2025, Vaidya Sane Ayurved Laboratories had annual revenue of 898.47M, down -9.55%.
Revenue (ttm)
979.90M
Revenue Growth
+8.84%
P/S Ratio
2.30
Revenue / Employee
1.54M
Employees
636
Market Cap
2.26B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Eye Hospital and Institute | 516.17M |
| Maitreya Medicare | 459.99M |
| Unihealth Hospitals | 789.82M |
| Max India | 1.84B |
| Sangani Hospitals | 316.49M |
| GPT Healthcare | 4.48B |
| Aatmaj Healthcare | 218.36M |
| Shalby | 11.19B |